These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cytomegalovirus disease in liver transplant recipients. Jeng LB; Lee WC; Wang CC; Wang KL; Chen SC; Chen MF; Chien RN; Chiu CT; Lin DY; Tan PP Transplant Proc; 1994 Aug; 26(4):2227-8. PubMed ID: 8066727 [No Abstract] [Full Text] [Related]
11. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation. Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289 [TBL] [Abstract][Full Text] [Related]
12. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021 [TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection in kidney transplantation: prophylaxis and management. Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286 [No Abstract] [Full Text] [Related]